Introduction

!
Simultaneous presence of esophageal varices (EV)
and achalasia is an uncommon clinical scenario. Previous reports suggest placement of a transjugular intrahepatic portosystemic shunt (TIPS) and surgical myotomy or endoscopy therapy for treatment [1] . For patients who are not candidates for a TIPS, injection of the lower esophageal sphincter with botulinum toxin under endoscopic ultrasound (EUS) has been described [2 -3] but it offers only short-term relief.
Case Report
!
We report the case of a 64-year-old man who received anticoagulant therapy with warfarin for a myeloproliferative disorder with a history of portal thrombosis. The patient's main complaints were chronic esophageal dysphagia to solids and daily regurgitation of undigested food. He also reported weight loss of 30 kg in the last 6 months (total Eckardt score of 10, representing the sum of the symptom scores for dysphagia, regurgitation, chest pain and weight loss [4] ). He did not have any history of EV band ligation. His physical exam was unremarkable aside from cachexia. Upper endoscopy showed a dilated esophagus above a contracted lower esophageal sphincter and grade 3 EV. An EUS (• " Fig. 1 ) and thoracic scan both showed absence of external compression or neoplastic disease and the presence of esophageal collateral venous circulation. Manometry (• " Fig.2 ) confirmed the diagnosis of type 1 achalasia. Placement of a TIPS was contraindicated by presence of an extensive chronic portal thrombosis with cavernoma. The case was reviewed and discussed in a multidisciplinary meeting involving thoracic surgeons and advanced endoscopists experienced with Heller myotomy and POEM. Those two ther- Background and study aims: Previous reports of simultaneous presence of esophageal varices (EV) and achalasia suggest placement of a transjugular intrahepatic portosystemic shunt (TIPS) and surgical myotomy or endoscopic therapy. We report the case of a 64-year-old man who received anticoagulant therapy for a myeloproliferative disorder with extensive portal thrombosis which was a contraindication to placement of a TIPS. apeutic options were rejected because of the presence of numerous varices. The patient was switched to low-molecular-weight heparin for anticoagulation and it was withheld before every endoscopic procedure. Over a period of 8 weeks, three endoscopic band ligation sessions were practiced to eradicate the EV. Once the varices were eradicated, with the patient under general anesthesia, we proceeded to pneumatically dilate his lower esophageal sphincter with a Rigiflex II TM 30-mm dilation balloon (• " Fig.3 ). The balloon was placed at the level of the lower esophageal sphincter and inflated to 20 psi for 30 seconds under fluoroscopic guidance. The endoscope was then reinserted to appreciate the dilation wound with visible muscle fibers (• " Fig. 4 ). Soft venous bleeding was noted. Mainly for bleeding prophylaxis, we proceeded to implant a SX-ELLA Stent Danis TM (25 × 135 mm covered metal stent) using the standard delivery technique with inflation of a gastric balloon wedged under the cardia (• " Fig.5 ). Again, fluoroscopic guidance was used. The patient resumed normal oral intake the day after both procedures and no complications were noted. A week after the procedure, the patient was electively admitted for stent removal. A system consisting of a hook and an extractor was used, making the recapture less traumatic. The patient was discharged the same day. Clinical follow-up a month later confirmed the resolution of his dysphagia (total Eckhart score of 1). A brief case presentation and the endoscopic procedures are shown in a short video available online (• " Video 1).
Conclusion
To our knowledge, this is the first reported case of endoscopic balloon dilation for achalasia on a patient with EV without previous placement of a TIPS. This sequence of endoscopic techniques is safe and feasible in this rare and difficult therapeutic situation and it is a permanent solution for patients with EV for whom TIPS is unsuitable. Previous reports have described injection of botulinum toxin under EUS guidance but that option offers only temporary relief. The risk of hemorrhagic complications may be reduced with a covered esophageal stent implanted with a nontraumatic recapture system. 
Video 1
Case presentation. Online content including video sequences viewable at: http://dx.doi.org/10.1055/s-0042-103240
